• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用立体选择性分析方法研究氯胺酮对映体在手术患者中的药代动力学和药效学。

Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method.

作者信息

Geisslinger G, Hering W, Thomann P, Knoll R, Kamp H D, Brune K

机构信息

Department of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nuernberg, Germany.

出版信息

Br J Anaesth. 1993 Jun;70(6):666-71. doi: 10.1093/bja/70.6.666.

DOI:10.1093/bja/70.6.666
PMID:8329260
Abstract

In a randomized, double-blind study, we have examined the stereoselective disposition and pharmacodynamic characteristics of ketamine in surgical patients after i.v. administration of S(+)-ketamine 1 mg/kg body weight (25 patients) or racemic ketamine 2 mg/kg body weight (25 patients). S(+)-Ketamine was not inverted to R(-)-ketamine. After racemate administration we observed statistically significant (P < 0.01) smaller clearance and volume of distribution for R(-)-ketamine compared with S(+)-ketamine. In contrast, the pharmacokinetic variables of S(+)-ketamine were not significantly different between treatment groups. Systolic and diastolic arterial pressure and heart rate increased significantly (P < 0.005) in both groups. At 1, 3 and 15 min after S(+)-ketamine administration, significantly greater increase in systolic and diastolic pressures were observed compared with the racemate group. There was no correlation between the changes in haemodynamic variables and plasma catecholamine concentrations, which remained unaffected after administration of the medications.

摘要

在一项随机双盲研究中,我们研究了静脉注射1 mg/kg体重的S(+)-氯胺酮(25例患者)或2 mg/kg体重的消旋氯胺酮(25例患者)后,氯胺酮在手术患者中的立体选择性处置和药效学特征。S(+)-氯胺酮未转化为R(-)-氯胺酮。给予消旋体后,我们观察到与S(+)-氯胺酮相比,R(-)-氯胺酮的清除率和分布容积在统计学上显著更小(P < 0.01)。相比之下,S(+)-氯胺酮的药代动力学变量在治疗组之间无显著差异。两组的收缩压和舒张压以及心率均显著升高(P < 0.005)。在给予S(+)-氯胺酮后1、3和15分钟,与消旋体组相比,收缩压和舒张压的升高显著更大。血流动力学变量的变化与血浆儿茶酚胺浓度之间无相关性,给药后血浆儿茶酚胺浓度未受影响。

相似文献

1
Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method.采用立体选择性分析方法研究氯胺酮对映体在手术患者中的药代动力学和药效学。
Br J Anaesth. 1993 Jun;70(6):666-71. doi: 10.1093/bja/70.6.666.
2
Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration during isoflurane anaesthesia in Shetland ponies.在设得兰矮种马异氟烷麻醉期间给予消旋氯胺酮或S-氯胺酮后氯胺酮和去甲氯胺酮的立体选择性药代动力学
Br J Anaesth. 2007 Feb;98(2):204-12. doi: 10.1093/bja/ael336. Epub 2007 Jan 11.
3
[The action of S-(+)-ketamine on serum catecholamine and cortisol. A comparison with ketamine racemate].[S-(+)-氯胺酮对血清儿茶酚胺和皮质醇的作用。与消旋氯胺酮的比较]
Anaesthesist. 1992 Oct;41(10):597-603.
4
Plasma free norepinephrine and epinephrine concentrations following diazepam-ketamine induction in patients undergoing cardiac surgery.心脏手术患者在接受地西泮-氯胺酮诱导后的血浆游离去甲肾上腺素和肾上腺素浓度。
Acta Anaesthesiol Scand. 1978;22(6):593-600. doi: 10.1111/j.1399-6576.1978.tb01342.x.
5
Stereoselective pharmacokinetics of ketamine: R(-)-ketamine inhibits the elimination of S(+)-ketamine.氯胺酮的立体选择性药代动力学:R(-)-氯胺酮抑制S(+)-氯胺酮的消除。
Clin Pharmacol Ther. 2001 Nov;70(5):431-8. doi: 10.1067/mcp.2001.119722.
6
Pharmacokinetics of ketamine and its major metabolites norketamine, hydroxynorketamine, and dehydronorketamine: a model-based analysis.基于模型的分析:氯胺酮及其主要代谢物去甲氯胺酮、羟基去甲氯胺酮和去氢去甲氯胺酮的药代动力学。
Br J Anaesth. 2020 Nov;125(5):750-761. doi: 10.1016/j.bja.2020.06.067. Epub 2020 Aug 21.
7
Cognitive impairment after small-dose ketamine isomers in comparison to equianalgesic racemic ketamine in human volunteers.
Anesthesiology. 2002 Feb;96(2):357-66. doi: 10.1097/00000542-200202000-00022.
8
Atrial natriuretic peptide responses during anaesthesia in patients with refractory cardiomyopathies.难治性心肌病患者麻醉期间的心房利钠肽反应。
Can J Anaesth. 1991 Jul;38(5):572-7. doi: 10.1007/BF03008186.
9
Stereoselective pharmacokinetics of ketamine and norketamine after constant rate infusion of a subanesthetic dose of racemic ketamine or S-ketamine in Shetland ponies.在设得兰矮种马中持续输注亚麻醉剂量的消旋氯胺酮或S-氯胺酮后,氯胺酮和去甲氯胺酮的立体选择性药代动力学。
Am J Vet Res. 2009 Jul;70(7):831-9. doi: 10.2460/ajvr.70.7.831.
10
Cerebral physiological responses to bolus injection of racemic, S(+)- or R(-)-ketamine in the pig.猪体内对大剂量注射消旋、S(+)-或R(-)-氯胺酮的脑生理反应。
Acta Anaesthesiol Scand. 2005 Nov;49(10):1436-42. doi: 10.1111/j.1399-6576.2005.00838.x.

引用本文的文献

1
Ketamine-From an Anesthetic to a Psychiatric Drug: Mechanisms of Action, Clinical Applications and Potential Risks.氯胺酮——从麻醉剂到精神科药物:作用机制、临床应用及潜在风险
Molecules. 2025 Jun 30;30(13):2824. doi: 10.3390/molecules30132824.
2
Ketamine, Esketamine, and Arketamine: Their Mechanisms of Action and Applications in the Treatment of Depression and Alleviation of Depressive Symptoms.氯胺酮、艾氯胺酮和阿氯胺酮:它们的作用机制及在抑郁症治疗和缓解抑郁症状中的应用。
Biomedicines. 2024 Oct 9;12(10):2283. doi: 10.3390/biomedicines12102283.
3
Nitric Oxide Donor Sodium Nitroprusside Reduces Racemic Ketamine-But Not Esketamine-Induced Pain Relief.
一氧化氮供体硝普钠可减轻消旋氯胺酮诱导的疼痛,但不能减轻艾氯胺酮诱导的疼痛缓解。
ACS Pharmacol Transl Sci. 2024 Jun 21;7(7):2044-2053. doi: 10.1021/acsptsci.4c00133. eCollection 2024 Jul 12.
4
A meta-analysis of the effects of ketamine on suicidal ideation in depression patients.一项关于氯胺酮对抑郁症患者自杀意念影响的荟萃分析。
Transl Psychiatry. 2024 Jun 10;14(1):248. doi: 10.1038/s41398-024-02973-1.
5
Exploring the multifaceted potential of (R)-ketamine beyond antidepressant applications.探索(R)-氯胺酮在抗抑郁应用之外的多方面潜力。
Front Pharmacol. 2024 Apr 11;15:1337749. doi: 10.3389/fphar.2024.1337749. eCollection 2024.
6
Ketamine in Chronic Pain: A Review.氯胺酮治疗慢性疼痛:综述
Cureus. 2024 Feb 1;16(2):e53365. doi: 10.7759/cureus.53365. eCollection 2024 Feb.
7
Antidepressants enter cells, organelles, and membranes.抗抑郁药进入细胞、细胞器和膜。
Neuropsychopharmacology. 2024 Jan;49(1):246-261. doi: 10.1038/s41386-023-01725-x. Epub 2023 Oct 2.
8
Analysis of the efficacy of subclinical doses of esketamine in combination with propofol in non-intubated general anesthesia procedures - a systematic review and meta-analysis.分析亚临床剂量的依托咪酯与丙泊酚联合用于非插管全身麻醉程序的疗效-系统评价和荟萃分析。
BMC Anesthesiol. 2023 Jul 21;23(1):245. doi: 10.1186/s12871-023-02135-8.
9
Pharmacokinetics of Nasal Esketamine in Patients with Allergic Rhinitis with and Without Nasal Decongestant Pretreatment and in Healthy Subjects with and Without Nasal Corticosteroid Pretreatment.鼻用依他佐辛在伴有或不伴有鼻用减充血剂预处理的变应性鼻炎患者和伴有或不伴有鼻用皮质类固醇预处理的健康受试者中的药代动力学。
Clin Pharmacokinet. 2023 Sep;62(9):1315-1328. doi: 10.1007/s40262-023-01273-z. Epub 2023 Jul 4.
10
The antidepressant effect and safety of non-intranasal esketamine: A systematic review.非鼻腔内用依他佐辛的抗抑郁作用和安全性:系统评价。
J Psychopharmacol. 2022 May;36(5):531-544. doi: 10.1177/02698811221084055. Epub 2022 May 12.